Drug Profile
LA heparin
Latest Information Update: 24 Jul 1998
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Anticoagulants; Antihyperlipidaemics; Antithrombotics; Low molecular weight heparins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis
Most Recent Events
- 24 Jul 1998 No-Development-Reported for Atherosclerosis in Sweden (Unknown route)
- 01 Sep 1995 Preclinical development for Atherosclerosis in Sweden (Unknown route)
- 10 Aug 1995 New profile